跳至主要内容
临床试验/IRCT20090117001556N131
IRCT20090117001556N131尚未招募2 期

Theanine as an adjuvant therapy in the treatment of major depressive disorder: a double-blind, randomized, placebo-controlled clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Diagnosis of major depressive disorder, based on DSM-5
  • Age between 18 to 60 years
  • The minimum score of 19, based on Hamilton depression scale

排除标准

  • Drug use during 1 year prior to trial (except nicotine)
  • Receive psychotropic drugs during 1 month prior to trial
  • History of Electroconvulsive therapy, two months prior to the trial
  • History of at least one period of mania or hypomania or mixed
  • Serious suicidal thoughts (The score of >2 in Hamilton depression scale, the suicidal tendencies section)
  • Kidney, liver, cardiovascular, or thyroid disorders
  • Pregnant or lactating women
  • Presence of concomitant psychiatric disorders
  • The patient's own request to leave the study

研究者

相似试验